Open official notice

協和薬品工業株式会社 “Medicines: Suratomin, Astocal, Vita Alto, Taftomin D, Zeory Ace” - Recall

Official notice

21 Nov 2002

Last checked

28 Oct 2026

RecallScope risk estimate:Not specifiedCAA Japan

An official CAA Japan notice concerns 協和薬品工業株式会社 “Medicines: Suratomin, Astocal, Vita Alto, Taftomin D, Zeory Ace” - Recall. Inadequate storage conditions for some raw materials caused cloudiness in products manufactured using those materials. The affected lots will therefore be voluntarily recalled. [Specific potential health effects] The products have been confirmed to meet all product specifications other than appearance, and there is considered to be no risk of adverse health effects. No adverse health effects associated with these products have been reported to date. Published 2002-11-21.

What to do now

Consumer instructions are not currently available in RecallScope. Check the official notice for what to do.

Units affected

3,870,000

Official notice

2002-11-21

The hazard

Inadequate storage conditions for some raw materials caused cloudiness in products manufactured using those materials. The affected lots will therefore be voluntarily recalled. [Specific potential health effects] The products have been confirmed to meet all product specifications other than appearance, and there is considered to be no risk of adverse health effects. No adverse health effects associated with these products have been reported to date.

How to check if you're affected

Product identifiers are not currently available in RecallScope. Check the official notice before deciding whether your item is affected.

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

医薬品 スラトミン アストカル ビタアルト タフトミンD ゼオリーエース

Units affected

3,870,000

Hazard

Inadequate storage conditions for some raw materials caused cloudiness in products manufactured using those materials. The affected lots will therefore be voluntarily recalled. [Specific potential health effects] The products have been confirmed to meet all product specifications other than appearance, and there is considered to be no risk of adverse health effects. No adverse health effects associated with these products have been reported to date.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

協和薬品工業

Manufacturer

連絡先:協和薬品工業株式会社

Phone

058-245-4138

Brand: 協和薬品工業. Contact: 連絡先:協和薬品工業株式会社. Phone 058-245-4138.

Source & status

Source

Tier

official

Category

HEALTH

Official classification

消費者庁 — 回収

Recall details

Event id

CAA-00000002578

Units affected

3,870,000

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 21 Nov 2002. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button